Full Text
Cost-Effectiveness of Ponatinib in The Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece

Abstract

Authors

G Gourzoulidis G Kourlaba P Giannoulia P Panagiotidis N Maniadakis

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×